KRAS and ovarian cancer: Here we have applied an in-depth quantitative proteomic approach [16]–[18] to the analysis of plasma protein changes related to tumor development in a K-ras/Pten ovarian cancer mouse model to determine their involvement in pathways and networks and their correspondence to proteins expressed or released from human ovarian cancer cells.